Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
8.79
+0.59 (7.20%)
Jan 7, 2026, 4:00 PM EST - Market closed
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $225.15 million as of January 8, 2026. Its market cap has increased by 147.94% in one year.
Market Cap
225.15M
Enterprise Value
189.71M
1-Year Change
147.94%
Ranking
Category
Stock Price
$8.79
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $225.15M, an increase of 288.16%. That is a compound annual growth rate of 41.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 210.04M | 8.61% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 989.89B |
| Johnson & Johnson | 498.00B |
| AbbVie | 406.59B |
| UnitedHealth Group | 308.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 273.02B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |